SCHEMBL10022040

SCHEMBL10022040

O=NC(CO)C(O)C(O)CO

nearest known ligand 0.50

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
TDP1 Q9NUW8 1/20 0.48
PDE4A P27815 1/20 0.41
USP2 O75604 1/20 0.38
SLCO1B1 Q9Y6L6 1/20 0.38
KDM4E B2RXH2 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18023456 0.90 TDP1 (0.57) LMNAL3MBTL1TDP1PDE4AUSP2
SCHEMBL14192906 0.86 LMNA (0.42) LMNAL3MBTL1TDP1PDE4AUSP2
SCHEMBL11941634 0.86 LMNA (0.35) LMNAL3MBTL1TDP1
SCHEMBL13841279 0.83
SCHEMBL12806699 0.77 TDP1 (0.36) TDP1
SCHEMBL14082117 0.77 LMNA (0.36) LMNAL3MBTL1TDP1PDE4A
SCHEMBL13995222 0.76
SCHEMBL29429791 0.76 LMNA (0.53) LMNAL3MBTL1TDP1PDE4AUSP2
SCHEMBL17993137 0.75 TDP1 (0.32) TDP1
SCHEMBL12514120 0.75 TDP1 (0.35) TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230051423-A1 ACTIVATABLE CYTOKINE POLYPEPTIDES AND METHODS OF USE THEREOF WEREWOLF THERAPEUTICS, INC. 2023-02-16 US disclosed
WO-2021078577-A1 ANTI-REDEPOSITION DETERGENTS HENKEL AG & CO. KGAA (DE) 2021-04-29 WO disclosed
US-20120065088-A1 SEQUENCE-SPECIFIC DETECTION OF NUCLEOTIDE SEQUENCES GEORGETOWN UNIVERSITY (US) 2012-03-15 US disclosed